FJR(SH:688272)2025-04-25 12:40Financial Performance - The company's operating revenue for Q1 2025 was ¥45,438,251.53, a decrease of 40.51% compared to ¥76,374,116.71 in the same period last year[4]. - The net profit attributable to shareholders was -¥10,641,181.25, representing a decline of 244.56% from a profit of ¥7,361,176.28 in the previous year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥10,680,929.97, down 247.83% from ¥7,225,057.38 year-on-year[4]. - The basic and diluted earnings per share were both -¥0.14, a decrease of 240% compared to ¥0.10 in the same period last year[4]. - The weighted average return on equity was -2.14%, a decrease of 3.62 percentage points from 1.49% in the previous year[4]. - The company reported a net loss of RMB 76,655,122.79 for the period, worsening from a loss of RMB 66,013,941.54 in the previous period[15]. - Operating profit for Q1 2025 was a loss of ¥10,592,129.34, compared to a profit of ¥7,386,756.99 in Q1 2024[18]. - Net loss for Q1 2025 was ¥10,641,181.25, compared to a net profit of ¥7,361,176.28 in Q1 2024[20]. Cash Flow - The net cash flow from operating activities was -¥41,715,316.43, compared to -¥29,138,911.54 in the same period last year, indicating a worsening cash flow situation[4]. - Cash flow from operating activities for Q1 2025 was a net outflow of ¥41,715,316.43, compared to a net outflow of ¥29,138,911.54 in Q1 2024[22]. - Cash flow from investing activities for Q1 2025 was a net outflow of ¥774,634.24, compared to a net outflow of ¥15,509,249.48 in Q1 2024[23]. - Cash flow from financing activities for Q1 2025 was a net inflow of ¥30,922,298.09, significantly up from ¥2,842,175.69 in Q1 2024[23]. - The company reported cash and cash equivalents at the end of Q1 2025 of ¥211,465,608.59, compared to ¥197,057,113.26 at the end of Q1 2024[23]. Research and Development - Research and development expenses totaled ¥11,446,366.07, down 26.91% from ¥15,660,473.31 year-on-year[4]. - Research and development expenses for Q1 2025 were ¥11,446,366.07, down 27% from ¥15,660,473.31 in Q1 2024[18]. - The proportion of R&D expenses to operating revenue increased to 25.19%, up 4.69 percentage points from 20.50% in the previous year[5]. Assets and Liabilities - Total assets at the end of the reporting period were ¥748,692,214.98, an increase of 1.67% from ¥736,385,404.96 at the end of the previous year[5]. - The company's current assets totaled RMB 628,751,288.44, up from RMB 613,005,171.01, indicating an increase of about 2.9%[13]. - Cash and cash equivalents decreased to RMB 211,465,608.59 from RMB 223,033,426.04, representing a decline of approximately 5.5%[13]. - Accounts receivable rose to RMB 228,890,464.02 from RMB 203,305,398.03, marking an increase of around 12.6%[13]. - The company's total liabilities increased to RMB 255,413,023.93 from RMB 233,086,315.08, which is an increase of about 9.6%[15]. - Short-term borrowings increased significantly to RMB 95,064,856.36 from RMB 60,043,704.16, reflecting a rise of approximately 58.3%[15]. - The total equity attributable to shareholders decreased to RMB 493,279,191.05 from RMB 503,299,089.88, a decline of about 2%[15]. - Shareholders' equity attributable to shareholders was ¥493,279,191.05, a decrease of 1.99% from ¥503,299,089.88 at the end of the previous year[5]. - Inventory levels increased slightly to RMB 165,084,544.10 from RMB 160,807,992.36, showing a growth of about 2.1%[13]. Product Development - The company has not reported any significant new product launches or technological advancements during this period[11].